Outsourced Pharma Announces Philadelphia Agenda
Erie, PA - Outsourced Pharma announces its Philadelphia agenda. Fundamentals for Outsourcing Drug Development and Manufacturing is scheduled for July 18 and 19, 2018 in Philadelphia. The full agenda can be found here.
Outsourced Pharma is expanding its conference line up in 2018, adding Philadelphia to the event locations of Boston, San Diego, and San Francisco. Philadelphia biotech and pharmaceutical company attendees can expect a thought leadership conference and exhibition that provides opportunities to learn about specific aspects of drug development and manufacturing outsourcing, interact with a cross-section of industry members, and generate new business opportunities.
“Over the past four years we’ve continued to improve upon our model of open discussion and debate to uncover challenges facing drug sponsors and the contract development and manufacturing organizations they work with. We look forward to building on our platform in 2018 with our inaugural conference in Philadelphia. We invite any professionals in the industry involved with outsourcing or an external supply chain to join us,” says Louis Garguilo, Chief Editor & Conference Chair, Outsourced Pharma.
The Philadelphia agenda is focused on the fundamentals for outsourcing drug development and manufacturing. Attendees can expect an open dialogue between panelists and the audience, discussing such topics as best practices for selecting the right CDMO, tech transfer challenges, and negotiating strategies for quality and supply agreements.
A featured session is Spotlight Technology: Cell Therapies Growing Strong in Philadelphia. T-cell innovation, genome editing, and FDA-approved gene therapy all happening in the Philadelphia area, some are calling this “Cellacon Valley.” But growth is contingent upon a vibrant ecosystem of networking and support, including from various service providers. Stakeholders in the Philly life sciences community discuss the challenges and opportunities in growing an innovation cluster, both here and beyond.
”When we started our outreach to the Philadelphia biopharma community for ideas for our technology session, the replies were universal,” says Garguilo. “Philly wants to talk cell and gene therapy, and we’ll have a great group of panelists to put these new technologies and therapies into the perspective of working with partners in order to advance outcomes.”
Outsourced Pharma Conference and Exhibition Dates:
Boston | May 14-15, 2018
Philadelphia | July 18-19, 2018
San Diego | August 21-22, 2018
San Francisco | October 29-30, 2018
About Outsourced Pharma
Outsourced Pharma provides comprehensive analysis and exclusive content from thought leaders for the advancement of global outsourcing of drug development and manufacturing. We offer readers of our website and participants of our conferences – our Outsourced Pharma community – a deeper exploration and understanding of the relationships between pharmaceutical and biotechnology organizations with their service providers, and an open channel of communication.
About Outsourced Pharma Conferences
Outsourced Pharma Conference & Exhibition is a vibrant forum for thought-leadership and the application of best practices for professionals engaged in outsourcing drug development and manufacturing. These conferences and exhibitions form a community for networking and discussing topics most relevant to sponsor-provider partnerships and supply-chain management, within an open format that promotes panel and attendee interaction.
About OutsourcedPharma.com
OutsourcedPharma.com provides comprehensive analysis of global outsourcing, the biotechnology and pharmaceutical industries, and their intersection with the overall life sciences and healthcare markets. We offer readers a deeper exploration and understanding of the relationships between service providers and their bio and pharma sponsors.
About Life Science Connect
Life Science Connect’s vision is to facilitate connections and foster collaborations in pharmaceutical, biotech, and medical device industries. We facilitate engagement across the drug development life cycle through our web portals, publications, events, and training.